Spen family transcriptional repressor (SPEN)

Spen family transcriptional repressor (SPEN) is a large, multi-domain nuclear protein characterized by several N-terminal RNA recognition motifs (RRMs) and a highly conserved C-terminal SPOC (Spen paralog and ortholog C-terminal) domain[2][3][6]. SPEN acts primarily as a transcriptional corepressor by recruiting chromatin-modifying complexes—such as HDAC- and deacetylase-containing complexes (SMRT/NCoR, NuRD)—to gene regulatory regions, thereby facilitating chromatin silencing and gene repression[1][6][7]. It can also bind both DNA and RNA, especially regulatory noncoding RNAs like SRA and XIST, mediating epigenetic regulation in processes such as X-chromosome inactivation[3][5][6]. SPEN is crucial for the regulation of key developmental signaling pathways, such as Notch and nuclear receptor signaling, and plays essential roles in neuronal differentiation, cell fate determination, and possibly in alternative splicing (in smaller related proteins)[1][2][5]. Pathogenic SPEN mutations are strongly associated with autism spectrum disorder and other neurodevelopmental diseases, highlighting its importance in brain development[4]. There are no currently known drugs that target SPEN directly.

Other names

Msx2-interacting proteinKIAA0929MINTSHARPRBM15CSMART/HDAC1-associated repressor proteinHIAA0929RATARSMsx2 interacting nuclear target (MINT) homologSPEN homologtranscriptional regulator

Not known for any approved small molecules or drugs. Endogenous: recruitment of corepressor complexes (e.g., SMRT/NCoR, HDAC), interaction with noncoding RNAs (SRA, XIST), interference with transcriptional activators[1][2][3][5][6].